232. Carney complex Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 2 / Drugs : 4 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 28
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Laboratory biomarker analysis
National Cancer Institute (NCI)
2012 Phase 2 NCT01560260 United States
Linsitinib
National Cancer Institute (NCI)
2012 Phase 2 NCT01560260 United States
Ocrh
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1995 - NCT00001452 United States
Pharmacological study
National Cancer Institute (NCI)
2012 Phase 2 NCT01560260 United States
National Cancer Institute (NCI)
2012 Phase 2 NCT01560260 United States
Linsitinib
National Cancer Institute (NCI)
2012 Phase 2 NCT01560260 United States
Ocrh
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1995 - NCT00001452 United States
Pharmacological study
National Cancer Institute (NCI)
2012 Phase 2 NCT01560260 United States